Literature DB >> 16182178

Cardiac manifestations of graft-versus-host disease.

Cynthia Rackley1, Kirk R Schultz, Frederick D Goldman, Ka Wah Chan, Amy Serrano, James E Hulse, Andrew L Gilman.   

Abstract

Graft-versus-host disease (GVHD) is a major cause of morbidity and mortality after bone marrow transplantation. Well-documented manifestations of GVHD include dermatologic, gastrointestinal, hepatic, pulmonary, musculoskeletal, and hematologic manifestations and sicca syndrome. To date, the heart has only rarely been reported to be a target of GVHD. We report a series of patients who developed bradycardia, coronary artery disease, or cardiomyolysis in association with acute or chronic GVHD. The severity of these manifestations ranged from asymptomatic to fatal. The bradycardias were responsive to increased immunosuppression. Although they are uncommon, it is important to recognize these cardiac manifestations, because they may reflect GVHD activity and may be reversible by increasing immunosuppression.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16182178     DOI: 10.1016/j.bbmt.2005.07.002

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN: 1083-8791            Impact factor:   5.742


  20 in total

1.  Acute pericarditis before engraftment in hematopoietic stem cell transplantation.

Authors:  A Shinohara; A Honda; A Nukina; K Takaoka; A Tsukamoto; S Hangai; Y Kogure; T Kobayashi; S Yamazaki; K Ueda; F Nakamura; Y Nannya; M Kurokawa
Journal:  Bone Marrow Transplant       Date:  2015-11-23       Impact factor: 5.483

Review 2.  Vascular Toxicity in Patients with Cancer: Is There a Recipe to Clarify Treatment? CME.

Authors:  Jose Alvarez-Cardona; Joshua Mitchell; Daniel Lenihan
Journal:  Methodist Debakey Cardiovasc J       Date:  2019 Oct-Dec

3.  Late congestive heart failure after hematopoietic cell transplantation.

Authors:  Saro H Armenian; Can-Lan Sun; Liton Francisco; Julia Steinberger; Seira Kurian; F Lennie Wong; Jon Sharp; Richard Sposto; Stephen J Forman; Smita Bhatia
Journal:  J Clin Oncol       Date:  2008-09-22       Impact factor: 44.544

4.  NIH Consensus development project on criteria for clinical trials in chronic graft-versus-host disease: II. The 2014 Pathology Working Group Report.

Authors:  Howard M Shulman; Diana M Cardona; Joel K Greenson; Sangeeta Hingorani; Thomas Horn; Elisabeth Huber; Andreas Kreft; Thomas Longerich; Thomas Morton; David Myerson; Victor G Prieto; Avi Rosenberg; Nathaniel Treister; Kay Washington; Mirjana Ziemer; Steven Z Pavletic; Stephanie J Lee; Mary E D Flowers; Kirk R Schultz; Madan Jagasia; Paul J Martin; Georgia B Vogelsang; David E Kleiner
Journal:  Biol Blood Marrow Transplant       Date:  2015-01-29       Impact factor: 5.742

5.  Very late-onset reversible cardiomyopathy in patients with chronic GvHD.

Authors:  H Kawano; H Tanaka; T Yamashita; K-I Hirata; S Ishii; T Suzuki; K Wakahashi; Y Kawano; A Sada; K Minagawa; F Kawakami; T Itoh; A Baba; T Matsui; Y Katayama
Journal:  Bone Marrow Transplant       Date:  2015-03-23       Impact factor: 5.483

Review 6.  Chronic graft-versus-host disease (GVHD) in children.

Authors:  Kristin Baird; Kenneth Cooke; Kirk R Schultz
Journal:  Pediatr Clin North Am       Date:  2010-02       Impact factor: 3.278

7.  PD-L1 Prevents the Development of Autoimmune Heart Disease in Graft-versus-Host Disease.

Authors:  Kathryn W Juchem; Faruk Sacirbegovic; Cuiling Zhang; Arlene H Sharpe; Kerry Russell; Jennifer M McNiff; Anthony J Demetris; Mark J Shlomchik; Warren D Shlomchik
Journal:  J Immunol       Date:  2017-12-06       Impact factor: 5.422

8.  Polymyositis after donor lymphocyte infusion.

Authors:  Juan Montoro; Juan Carlos Hernández-Boluda; Cristina Arbona; Carlos Solano
Journal:  Int J Hematol       Date:  2012-08-19       Impact factor: 2.490

Review 9.  Long-term consequences of hematopoietic stem cell transplantation: current state of the science.

Authors:  K Scott Baker; Saro Armenian; Smita Bhatia
Journal:  Biol Blood Marrow Transplant       Date:  2009-09-24       Impact factor: 5.742

10.  Large vessel vasculitis: manifestation of graft-versus-host disease?

Authors:  P Sostak; T Saam; M Hacker; Ch Schankin; J Wagner; H J Kolb; A Straube
Journal:  J Neurol       Date:  2009-08-05       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.